Patents by Inventor Orphagen Pharmaceuticals

Orphagen Pharmaceuticals has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA
    Publication number: 20130150333
    Abstract: Methods for modulating (inhibiting or stimulating) retinoid-related orphan receptor ? (ROR?) activity. This modulation has numerous effects, including inhibition of TH-17 cell function and/or TH-17 cell activity, and inhibition of re-stimulation of TH-17 cells, which are beneficial to treatment of inflammation and autoimmune disorders. Stimulation of ROR? results in stimulation of TH-17 cell function and/or activity which is beneficial for immune-enhancing compositions (e.g., vaccines).
    Type: Application
    Filed: February 13, 2013
    Publication date: June 13, 2013
    Applicant: ORPHAGEN PHARMACEUTICALS
    Inventor: Orphagen Pharmaceuticals